;PMID: 2983957
;source_file_1928.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..34] = [t:0..34]
;1)sentence:[e:40..117] = [t:40..117]
;2)section:[e:121..174] = [t:121..174]
;3)sentence:[e:178..285] = [t:178..285]
;4)sentence:[e:286..462] = [t:286..462]
;5)sentence:[e:463..588] = [t:463..588]
;6)sentence:[e:589..733] = [t:589..733]
;7)sentence:[e:734..857] = [t:734..857]
;8)sentence:[e:858..966] = [t:858..966]
;9)sentence:[e:967..1199] = [t:967..1199]
;10)section:[e:1203..1247] = [t:1203..1247]

;section 0 Span:0..34
;Dig Dis Sci. 1985 Apr;30(4):334-9.
(SEC
  (FRAG (NNP:[0..3] Dig) (NNP:[4..7] Dis) (NNP:[8..11] Sci) (.:[11..12] .)
        (CD:[13..17] 1985) (.:[18..24] Apr;30) (-LRB-:[24..25] -LRB-)
        (NN:[25..26] 4) (-RRB-:[26..27] -RRB-) (::[27..28] :) (CD:[28..31] 334)
        (::[31..32] -) (CD:[32..34] 9.)))

;sentence 1 Span:40..117
;Inhibition of cytochrome P-450-dependent mixed function oxidation by
;ethanol.
;[54..70]:cyp450:"cytochrome P-450"
;[109..116]:substance:"ethanol"
(SENT
  (NP-HLN
    (NP (NN:[40..50] Inhibition))
    (PP (IN:[51..53] of)
      (NP
        (ADJP
          (NML (NN:[54..64] cytochrome) (NN:[65..70] P-450))
          (HYPH:[70..71] -) (JJ:[71..80] dependent))
        (NML (VBN:[81..86] mixed) (NN:[87..95] function))
        (NN:[96..105] oxidation)))
    (PP (IN:[106..108] by)
      (NP (NN:[109..116] ethanol)))
    (.:[116..117] .)))

;section 2 Span:121..174
;Hayashi N, Kamada T, Sato N, Kasahara A, Peterson JA.
(SEC
  (FRAG (NNP:[121..128] Hayashi) (NNP:[129..130] N) (,:[130..131] ,)
        (NNP:[132..138] Kamada) (NNP:[139..140] T) (,:[140..141] ,)
        (NNP:[142..146] Sato) (NNP:[147..148] N) (,:[148..149] ,)
        (NNP:[150..158] Kasahara) (NNP:[159..160] A) (,:[160..161] ,)
        (NNP:[162..170] Peterson) (NNP:[171..173] JA) (.:[173..174] .)))

;sentence 3 Span:178..285
;The mechanism of inhibition of cytochrome P-450-dependent mixed function 
;oxidation by ethanol was studied.
;[209..225]:cyp450:"cytochrome P-450"
;[265..272]:substance:"ethanol"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[178..181] The) (NN:[182..191] mechanism))
      (PP (IN:[192..194] of)
        (NP
          (NP (NN:[195..205] inhibition))
          (PP (IN:[206..208] of)
            (NP
              (ADJP
                (NML (NN:[209..219] cytochrome) (NN:[220..225] P-450))
                (HYPH:[225..226] -) (JJ:[226..235] dependent))
              (NML (VBN:[236..241] mixed) (NN:[242..250] function))
              (NN:[252..261] oxidation)))
          (PP (IN:[262..264] by)
            (NP (NN:[265..272] ethanol))))))
    (VP (VBD:[273..276] was)
      (NP (VBN:[277..284] studied)
        (NP-1 (-NONE-:[284..284] *))))
    (.:[284..285] .)))

;sentence 4 Span:286..462
;Ethanol competitively inhibited the binding of  hexobarbital to liver
;microsomes, and increased the low spin signal of  cytochrome P-450 in the
;electron spin resonance spectra.
;[286..293]:substance:"Ethanol"
;[334..346]:substance:"hexobarbital"
;[406..422]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ (NN:[286..293] Ethanol))
    (VP
      (VP
        (ADVP (RB:[294..307] competitively))
        (VBD:[308..317] inhibited)
        (NP
          (NP (DT:[318..321] the) (NN:[322..329] binding))
          (PP (IN:[330..332] of)
            (NP (NN:[334..346] hexobarbital)))
          (PP (TO:[347..349] to)
            (NP (NN:[350..355] liver) (NNS:[356..366] microsomes)))))
      (,:[366..367] ,) (CC:[368..371] and)
      (VP (VBD:[372..381] increased)
        (NP
          (NP (DT:[382..385] the)
            (NML (JJ:[386..389] low) (NN:[390..394] spin))
            (NN:[395..401] signal))
          (PP (IN:[402..404] of)
            (NP (NN:[406..416] cytochrome) (NN:[417..422] P-450))))
        (PP-LOC (IN:[423..425] in)
          (NP (DT:[426..429] the)
            (NML (NN:[430..438] electron) (NN:[439..443] spin))
            (NN:[444..453] resonance) (NNS:[454..461] spectra)))))
    (.:[461..462] .)))

;sentence 5 Span:463..588
;Therefore, ethanol  decreased the substrates bound to ferric cytochrome P-450
;in the first step of  mixed function oxidation.
;[474..481]:substance:"ethanol"
;[497..507]:substance:"substrates"
;[517..540]:cyp450:"ferric cytochrome P-450"
(SENT
  (S
    (ADVP (RB:[463..472] Therefore))
    (,:[472..473] ,)
    (NP-SBJ (NN:[474..481] ethanol))
    (VP (VBD:[483..492] decreased)
      (NP
        (NP (DT:[493..496] the) (NNS:[497..507] substrates))
        (VP (VBN:[508..513] bound)
          (NP (-NONE-:[513..513] *))
          (PP (TO:[514..516] to)
            (NP (JJ:[517..523] ferric) (NN:[524..534] cytochrome)
                (NN:[535..540] P-450)))))
      (PP (IN:[541..543] in)
        (NP
          (NP (DT:[544..547] the) (JJ:[548..553] first) (NN:[554..558] step))
          (PP (IN:[559..561] of)
            (NP
              (NML (VBN:[563..568] mixed) (NN:[569..577] function))
              (NN:[578..587] oxidation))))))
    (.:[587..588] .)))

;sentence 6 Span:589..733
;The second step of mixed function oxidation is the  reduction of ferric
;cytochrome P-450-substrate complex by NADPH-cytochrome P-450  reductase.
;[654..695]:substance:"ferric cytochrome P-450-substrate complex"
;[699..732]:substance:"NADPH-cytochrome P-450  reductase"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[589..592] The) (JJ:[593..599] second) (NN:[600..604] step))
      (PP (IN:[605..607] of)
        (NP
          (NML (VBN:[608..613] mixed) (NN:[614..622] function))
          (NN:[623..632] oxidation))))
    (VP (VBZ:[633..635] is)
      (NP-PRD
        (NP (DT:[636..639] the) (NN:[641..650] reduction))
        (PP (IN:[651..653] of)
          (NP (JJ:[654..660] ferric)
            (NML
              (NML (NN:[661..671] cytochrome) (NN:[672..677] P-450))
              (HYPH:[677..678] -) (NN:[678..687] substrate))
            (NN:[688..695] complex)))
        (PP (IN:[696..698] by)
          (NP
            (NML (NN:[699..704] NADPH) (HYPH:[704..705] -)
                 (NN:[705..715] cytochrome) (NN:[716..721] P-450))
            (NN:[723..732] reductase)))))
    (.:[732..733] .)))

;sentence 7 Span:734..857
;The NADPH-dependent reduction of liver microsomal cytochrome P-450  was
;biphasic and composed of two first-order reactions.
;[738..743]:substance:"NADPH"
;[784..800]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[734..737] The)
        (ADJP (NN:[738..743] NADPH) (HYPH:[743..744] -)
              (JJ:[744..753] dependent))
        (NN:[754..763] reduction))
      (PP (IN:[764..766] of)
        (NP (NN:[767..772] liver) (JJ:[773..783] microsomal)
           (NN:[784..794] cytochrome) (NN:[795..800] P-450))))
    (VP (VBD:[802..805] was)
      (UCP
        (ADJP-PRD (JJ:[806..814] biphasic))
        (CC:[815..818] and)
        (VP (VBN:[819..827] composed)
          (NP-1 (-NONE-:[827..827] *))
          (PP-CLR (IN:[828..830] of)
            (NP (CD:[831..834] two)
              (NML (JJ:[835..840] first) (HYPH:[840..841] -)
                   (NN:[841..846] order))
              (NNS:[847..856] reactions))))))
    (.:[856..857] .)))

;sentence 8 Span:858..966
;Ethanol decreased the  rate constants of the fast and slow phases of
;microsomal cytochrome P-450  reduction.
;[858..865]:substance:"Ethanol"
;[938..954]:cyp450:"cytochrome P-450"
(SENT
  (S
    (NP-SBJ (NN:[858..865] Ethanol))
    (VP (VBD:[866..875] decreased)
      (NP
        (NP (DT:[876..879] the) (NN:[881..885] rate) (NNS:[886..895] constants))
        (PP (IN:[896..898] of)
          (NP
            (NP (DT:[899..902] the)
              (NML
                (NML (JJ:[903..907] fast)
                  (NML-1 (-NONE-:[907..907] *P*)))
                (CC:[908..911] and)
                (NML (JJ:[912..916] slow)
                  (NML-1 (NNS:[917..923] phases)))))
            (PP (IN:[924..926] of)
              (NP (JJ:[927..937] microsomal)
                (NML (NN:[938..948] cytochrome) (NN:[949..954] P-450))
                (NN:[956..965] reduction)))))))
    (.:[965..966] .)))

;sentence 9 Span:967..1199
;Thus, it is concluded that the inhibition of drug oxidation by  ethanol may
;be due to the displacement of substrates from cytochrome P-450 and  to the
;inhibition of reduction of cytochrome P-450 by NADPH-cytochrome P-450 
;reductase.
;[1012..1016]:substance:"drug"
;[1031..1038]:substance:"ethanol"
;[1073..1083]:substance:"substrates"
;[1089..1105]:cyp450:"cytochrome P-450"
;[1145..1161]:cyp450:"cytochrome P-450"
;[1165..1198]:substance:"NADPH-cytochrome P-450  reductase"
(SENT
  (S
    (ADVP (RB:[967..971] Thus))
    (,:[971..972] ,)
    (NP-SBJ-1
      (NP (PRP:[973..975] it))
      (SBAR-2 (-NONE-:[975..975] *ICH*)))
    (VP (VBZ:[976..978] is)
      (VP (VBN:[979..988] concluded)
        (NP-1 (-NONE-:[988..988] *))
        (SBAR-2 (IN:[989..993] that)
          (S
            (NP-SBJ
              (NP (DT:[994..997] the) (NN:[998..1008] inhibition))
              (PP (IN:[1009..1011] of)
                (NP (NN:[1012..1016] drug) (NN:[1017..1026] oxidation)))
              (PP (IN:[1027..1029] by)
                (NP (NN:[1031..1038] ethanol))))
            (VP (MD:[1039..1042] may)
              (VP (VB:[1043..1045] be)
                (PP-PRD (JJ:[1046..1049] due)
                  (PP
                    (PP (TO:[1050..1052] to)
                      (NP
                        (NP (DT:[1053..1056] the) (NN:[1057..1069] displacement))
                        (PP (IN:[1070..1072] of)
                          (NP
                            (NP (NNS:[1073..1083] substrates))
                            (PP (IN:[1084..1088] from)
                              (NP (NN:[1089..1099] cytochrome)
                                  (NN:[1100..1105] P-450)))))))
                    (CC:[1106..1109] and)
                    (PP (TO:[1111..1113] to)
                      (NP
                        (NP (DT:[1114..1117] the) (NN:[1118..1128] inhibition))
                        (PP (IN:[1129..1131] of)
                          (NP
                            (NP (NN:[1132..1141] reduction))
                            (PP (IN:[1142..1144] of)
                              (NP (NN:[1145..1155] cytochrome)
                                  (NN:[1156..1161] P-450)))))
                        (PP (IN:[1162..1164] by)
                          (NP
                            (NML (NN:[1165..1170] NADPH) (HYPH:[1170..1171] -)
                                 (NN:[1171..1181] cytochrome)
                                 (NN:[1182..1187] P-450))
                            (NN:[1189..1198] reductase)))))))))))))
    (.:[1198..1199] .)))

;section 10 Span:1203..1247
;PMID: 2983957 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1203..1207] PMID) (::[1207..1208] :) (CD:[1209..1216] 2983957)
        (NN:[1217..1218] -LSB-) (NNP:[1218..1224] PubMed) (::[1225..1226] -)
        (NN:[1227..1234] indexed) (IN:[1235..1238] for)
        (NNP:[1239..1247] MEDLINE-RSB-)))
